Publications

Vassallo, M , Fabre, R , Durant, J , Lebrun-Frenay, C , Joly, H , Ticchioni, M and al
A decreasing CD4/CD8 ratio over time and lower CSF-penetrating antiretroviral regimens are associated with a higher risk of neurocognitive deterioration, independently of viral replication.
J. Neurovirol. 2016
Gray, L , Falzon, C , Bergamaschi, A , Schuft, L , Durant, J , Rosenthal, E and al
Exercise stereotypes and health-related outcomes in French people living with HIV: development and validation of an HIV Exercise Stereotypes Scale (HIVESS).
Health Qual Life Outcomes 2016;14
Touboul-Lundgren, P , Bruno, P , Bailly, L , Dunais, B , Pradier, C
Paediatric antibiotic prescriptions in primary care in the Alpes-Maritimes area of southeastern France between 2008 and 2013.
Eur. J. Clin. Microbiol. Infect. Dis. 2016;
Feuillet, P , Lert, F , Tron, L , Aubriere, C , Spire, B , Dray-Spira, R
Prevalence of and factors associated with depression among people living with HIV in France.
HIV Med. 2016;
Agrinier, N , Le Maréchal, M , Fressard, L , Verger, P , Pulcini, C
Discrepancies between general practitioners' vaccination recommendations for their patients and practices for their children.
Clin. Microbiol. Infect. 2016;
Vassallo, M , De Monte, A , Durant, J , Dunais, B , Cottalorda, J
Selection of the R263K mutation to dolutegravir in cerebrospinal fluid HIV-1 virus in one patient with HIV-associated neurocognitive disorders.
AIDS 2016;30
David, R , Manera, V , Fabre, R , Pradier, C , Robert, P , Tifratene, K
Evolution of the Antidepressant Prescribing in Alzheimer's Disease and Related Disorders Between 2010 and 2014: Results from the French National Database on Alzheimer's Disease (BNA).
J. Alzheimers Dis. 2016;53
Malhotra-Kumar, S , Van Heirstraeten, L , Coenen, S , Lammens, C , Adriaenssens, N , Kowalczyk, A and al
Impact of amoxicillin therapy on resistance selection in patients with community-acquired lower respiratory tract infections: a randomized, placebo-controlled study.
J. Antimicrob. Chemother. 2016;71
Barraco, F , Labussière-Wallet, H , Valour, F , Ducastelle-Leprêtre, S , Nicolini, FE , Thomas, X and al
Actinomycosis after allogeneic hematopoietic stem cell transplantation despite penicillin prophylaxis.
Transpl Infect Dis 2016;18
Conrad, A , Le Maréchal, M , Dupont, D , Ducastelle-Leprêtre, S , Balsat, M , Labussière-Wallet, H and al
A matched case-control study of toxoplasmosis after allogeneic haematopoietic stem cell transplantation: still a devastating complication.
Clin. Microbiol. Infect. 2016;22
Kamara, DA , Smith, C , Ryom, L , Reiss, P , Rickenbach, M , Phillips, A and al
Longitudinal analysis of the associations between antiretroviral therapy, viraemia and immunosuppression with lipid levels: the D:A:D study.
Antivir. Ther. (Lond.) 2016;21
Flandre, P , Pugliese, P , Allavena, C , Katlama, C , Cotte, L , Cheret, A and al
Comparative risk of failure of ABC/3TC or TDF/FTC based first-line regimens in patients with a high viral load.
HIV Med. 2016;17
Grenier, F , Capriz, F , Lacroix-Hugues, V , Paysant, F , Pradier, C , Franco, A
Evaluation of French version of the Vulnerability to abuse screen scale (VASS), a elder abuse screening tool.
Geriatr Psychol Neuropsychiatr Vieil 2016;14
Hentzien, M , Dramé, M , Allavena, C , Jacomet, C , Valantin, MA , Cabié, A and al
Impact of Age-related Comorbidities on Five-year Overall Mortality among Elderly HIV-Infected Patients in the Late HAART Era--Role of Chronic Renal Disease.
J Nutr Health Aging 2016;20
Kovari, H , Sabin, CA , Ledergerber, B , Ryom, L , Reiss, P , Law, M and al
Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study.
Open Forum Infect Dis 2016;3
Shepherd, L , Borges, Á , Ledergerber, B , Domingo, P , Castagna, A , Rockstroh, J and al
Infection-related and -unrelated malignancies, HIV and the aging population.
HIV Med. 2016;17
Mocroft, A , Lundgren, JD , Ross, M , Fux, CA , Reiss, P , Moranne, O and al
Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study.
Lancet HIV 2016;3
Allavena, C , Katlama, C , Cotte, L , Roger, PM , Delobel, P , Cheret, A and al
Long-term efficacy and safety of etravirine-containing regimens in a real-life cohort of treatment-experienced HIV-1-infected patients.
Infect Dis (Lond) 2016;48
Suzan-Monti, M , Lorente, N , Demoulin, B , Marcellin, F , Préau, M , Dray-Spira, R and al
Sexual risk behaviour among people living with HIV according to the biomedical risk of transmission: results from the ANRS-VESPA2 survey.
J Int AIDS Soc 2016;19
Caisso, C , Payan, J , Dunais, B , Neri, D , Vassallo, M
A case of uveitis due to Rickettsia conorii infection in Southeastern France.
Ticks Tick Borne Dis 2016;7
Achhra, AC , Mocroft, A , Reiss, P , Sabin, C , Ryom, L , de Wit, S and al
Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study.
HIV Med. 2016;17
Xhaard, C , de Vathaire, F , Cléro, E , Maillard, S , Ren, Y , Borson-Chazot, F and al
Anthropometric Risk Factors for Differentiated Thyroid Cancer in Young Men and Women From Eastern France: A Case-Control Study.
Am. J. Epidemiol. 2015;182
Schultze, A , Phillips, AN , Paredes, R , Battegay, M , Rockstroh, JK , Machala, L and al
HIV resistance testing and detected drug resistance in Europe.
AIDS 2015;29
Fournier, M , Radel, R , Tifratene, K , Pradier, C , Fuch, A , Mossé, P and al
Protocol of the 'As du Coeur' study: a randomized controlled trial on physical activity maintenance in cardiovascular patients.
BMC Cardiovasc Disord 2016;16
Touboul Lundgren, P , Detanne, S , Dunais, B , Bruno, P , Bentz, L , Khouri, P and al
Promoting primary care screening for Chlamydia trachomatis infection.
Sante Publique 2016;28
Xhaard, C , Lence-Anta, JJ , Ren, Y , Borson-Chazot, F , Sassolas, G , Schvartz, C and al
Recreational Physical Activity and Differentiated Thyroid Cancer Risk: A Pooled Analysis of Two Case-Control Studies.
Eur Thyroid J 2016;5
Ryom, L , Lundgren, JD , Ross, M , Kirk, O , Law, M , Morlat, P and al
Renal Impairment and Cardiovascular Disease in HIV-Positive Individuals: The D:A:D Study.
J. Infect. Dis. 2016;214
Hyvernat, H , Barel, R , Gentilhomme, A , Césari-Giordani, JF , Freche, A , Kaidomar, M and al
Effects of Increasing Hydrocortisone to 300?mg Per Day in the Treatment of Septic Shock: a Pilot Study.
Shock 2016;46
Rodger, AJ , Cambiano, V , Bruun, T , Vernazza, P , Collins, S , van Lunzen, J and al
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy.
JAMA 2016;316
Naqvi A, Giordanengo V, Dunais B, de Salvador-Guillouet F, Perbost I, Durant J
Virological response and resistance mutations to NS3/4A inhibitors in hepatitis C virus-human immunodeficiency virus coinfection.
World J Hepatol 2015;7
Tifratene K, Robert P, Metelkina A, Pradier C, Dartigues JF
Progression of mild cognitive impairment to dementia due to AD in clinical settings.
Neurology 2015;85
Vassallo M, Durant J, Lebrun-Frenay C, Fabre R, Ticchioni M, Andersen S
Virologically suppressed patients with asymptomatic and symptomatic HIV-associated neurocognitive disorders do not display the same pattern of immune activation.
HIV Med. 2015;16
Hleyhel M, Belot A, Bouvier AM, Tattevin P, Pacanowski J, Genet P
Trends in survival after cancer diagnosis among HIV-infected individuals between 1992 and 2009. Results from the FHDH-ANRS CO4 cohort.
Int. J. Cancer 2015;137
Abgrall S, Rachas A, Tourret J, Isnard-Bagnis C, Billaud E, Tattevin P
A multifaceted intervention designed to improve medical management of moderate to advanced chronic kidney disease in HIV-infected patients: a cluster randomized trial.
Clin. Infect. Dis. 2015;61
Bailly L, Daurès JP, Dunais B, Pradier C
Bayesian estimation of a cancer population by capture-recapture with individual capture heterogeneity and small sample.
BMC Med Res Methodol 2015;15
Mocroft A, Lundgren JD, Ross M, Law M, Reiss P, Kirk O
Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study.
PLoS Med. 2015;12
Bruyand M, Ryom L, Shepherd L, Fatkenheuer G, Grulich A, Reiss P
Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: the D: A: D study.
J. Acquir. Immune Defic. Syndr. 2015;68
Dunais B, Bruno P, Touboul P, Degand N, Sakarovitch C, Fontas E
Impact of the 13-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae among children attending group daycare in southeastern France.
Pediatr. Infect. Dis. J. 2015;34
de Monteynard LA, Dray-Spira R, de Truchis P, Grabar S, Launay O, Meynard JL
Later cART initiation in migrant men from sub-Saharan Africa without advanced HIV disease in France.
PLoS ONE 2015;10
Marcellin F, Demoulin B, Spire B, Suzan-Monti M, Roux P, Protopopescu C
Spontaneous and post-treatment HCV clearance: relationships with health-related quality of life in HIV infection (ANRS-VESPA2 study).
Expert Rev Gastroenterol Hepatol 2015;9
Vassallo M, Dunais B, Roger PM
Antimicrobial lock therapy in central-line associated bloodstream infections: a systematic review.
Infection 2015;43
Grabar S, Tattevin P, Selinger-Leneman H, de La Blanchardiere A, de Truchis P, Rabaud C
Incidence of herpes zoster in HIV-infected adults in the combined antiretroviral therapy era: results from the FHDH-ANRS CO4 cohort.
Clin. Infect. Dis. 2015;60
Cain LE, Phillips A, Olson A, Sabin C, Jose S, Justice A
Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries.
Clin. Infect. Dis. 2015;60
Rosenthal E, Roussillon C, Salmon-Céron D, Georget A, Hénard S, Huleux T
Liver-related deaths in HIV-infected patients between 1995 and 2010 in France: the Mortavic 2010 study in collaboration with the Agence Nationale de Recherche sur le SIDA (ANRS) EN 20 Mortalité 2010 survey.
HIV Med. 2015;16
Delaugerre C, Ghosn J, Lacombe JM, Pialoux G, Cuzin L, Launay O
Significant reduction in HIV virologic failure during a 15-year period in a setting with free healthcare access.
Clin. Infect. Dis. 2015;60
Makinson A, Hayot M, Eymard-Duvernay S, Quesnoy M, Raffi F, Thirard L
High prevalence of undiagnosed COPD in a cohort of HIV-infected smokers.
Eur. Respir. J. 2015;45
Potard, V , Reynes, J , Ferry, T , Aubin, C , Finkielsztejn, L , Yazdanpanah, Y and al
Durability and Effectiveness of Maraviroc-Containing Regimens in HIV-1-Infected Individuals with Virological Failure in Routine Clinical Practice.
PLoS ONE 2015;10
Marcellin, F , Demoulin, B , Suzan-Monti, M , Maradan, G , Carrieri, MP , Dray-Spira, R and al
Risk Factors for HCV Reinfection or Transmission in HIV-HCV Coinfected MSM (ANRS-VESPA2 French National Survey).
J. Acquir. Immune Defic. Syndr. 2015;70
Poizot-Martin, I , Naqvi, A , Obry-Roguet, V , Valantin, MA , Cuzin, L , Billaud, E and al
Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected Patients.
PLoS ONE 2015;10
Cuzin, L , Pugliese, P , Allavena, C , Katlama, C , Cotte, L , Cheret, A and al
Comparative Effectiveness of First Antiretroviral Regimens in Clinical Practice Using a Causal Approach.
Medicine (Baltimore) 2015;94
Lodi, S , Phillips, A , Logan, R , Olson, A , Costagliola, D , Abgrall, S and al
Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study.
Lancet HIV 2015;2
Touboul-Lundgren, P , Jensen, S , Drai, J , Lindbæk, M
Identification of cultural determinants of antibiotic use cited in primary care in Europe: a mixed research synthesis study of integrated design 'Culture is all around us'.
BMC Public Health 2015;15
Cuzin, L , Pugliese, P , Sauné, K , Allavena, C , Ghosn, J , Cottalorda, J and al
Levels of intracellular HIV-DNA in patients with suppressive antiretroviral therapy.
AIDS 2015;29
Ciais, JF , Jacquin, PH , Pradier, C , Castelli-Prieto, M , Baudin, S , Tremellat, F
Using Sodium Oxybate (Gamma Hydroxybutyric Acid) for Deep Sedation at the End of Life.
J Palliat Med 2015;18
Annequin, M , Lert, F , Spire, B , Dray-Spira, R
Has the employment status of people living with HIV changed since the early 2000s?
AIDS 2015;29
Lang, S , Lacombe, JM , Mary-Krause, M , Partisani, M , Bidegain, F , Cotte, L and al
Is Impact of Statin Therapy on All-Cause Mortality Different in HIV-Infected Individuals Compared to General Population? Results from the FHDH-ANRS CO4 Cohort.
PLoS ONE 2015;10
Thouvenin, Y , Makinson, A , Cournil, A , Eymard-Duvernay, S , Lentz, P , Delemazure, AS and al
Chest Low-Dose Computed Tomography for Early Lung Cancer Diagnosis as an Opportunity to Diagnose Vertebral Fractures in HIV-Infected Smokers, an ANRS EP48 HIV CHEST Substudy.
J. Acquir. Immune Defic. Syndr. 2015;69
Podlekareva, D , Grint, D , Karpov, I , Rakmanova, A , Mansinho, K , Chentsova, N and al
Changing utilization of Stavudine (d4T) in HIV-positive people in 2006-2013 in the EuroSIDA study.
HIV Med. 2015;16
Maraux, B , Hamelin, C , Bajos, N , Dray-Spira, R , Spire, B , Lert, F
Women living with HIV still lack highly effective contraception: results from the ANRS VESPA2 study, France, 2011.
Contraception 2015;92
Boesecke, C , Grint, D , Soriano, V , Lundgren, JD , d'Arminio Monforte, A , Mitsura, VM and al
Hepatitis C seroconversions in HIV infection across Europe: which regions and patient groups are affected?
Liver Int. 2015;35
Grint, D , Peters, L , Rockstroh, JK , Rakmanova, A , Trofimova, T , Lacombe, K and al
Liver-related death among HIV/hepatitis C virus-co-infected individuals: implications for the era of directly acting antivirals.
AIDS 2015;29
Borges AH, Lundgren JD, Ridolfo A, Katlama C, Antunes F, Grzeszczuk A
Thrombocytopenia is associated with an increased risk of cancer during treated HIV disease.
AIDS 2014;28
Allavena C, Katlama C, Cotte L, Roger PM, Delobel P, Cheret A
Efficacy and tolerability of Etravirine in HIV-1 adult patients: Results of a large French prospective cohort.
J Int AIDS Soc 2014;17
Hatleberg CI, Ryom L, El-Sadr W, Mocroft A, Reiss P, de Wit S
Gender differences in HIV-positive persons in use of cardiovascular disease-related interventions: D:A:D study.
J Int AIDS Soc 2014;17
Uusküla A, Ricketts EJ, Rugman C, Kalda RR, Fredlund H, Hedlund J
Provision of chlamydia testing, and training of primary health care staff about chlamydia testing, across four European countries.
BMC Public Health 2014;14
Geri G, Maynard M, Rosenthal E, Fontaine H, Lacombe K, Slama L
Care of hepatitis C virus infection in France: modifications in three consecutive surveys between 1995 and 2010.
Liver Int. 2014;34
Xhaard C, Rubino C, Cléro E, Maillard S, Ren Y, Borson-Chazot F
Menstrual and reproductive factors in the risk of differentiated thyroid carcinoma in young women in France: a population-based case-control study.
Am. J. Epidemiol. 2014;180
Hleyhel M, Hleyhel M, Bouvier AM, Belot A, Tattevin P, Pacanowski J
Risk of non-AIDS-defining cancers among HIV-1-infected individuals in France between 1997 and 2009: results from a French cohort.
AIDS 2014;28
Potard V, Rey D, Poizot-Martin I, Mokhtari S, Pradier C, Rozenbaum W
Lopinavir/r no longer recommended as a first-line regimen: a comparative effectiveness analysis.
J Int AIDS Soc 2014;17
Pradier C, Sakarovitch C, Le Duff F, Layese R, Metelkina A, Anthony S
The mini mental state examination at the time of Alzheimer's disease and related disorders diagnosis, according to age, education, gender and place of residence: a cross-sectional study among the French National Alzheimer database.
PLoS ONE 2014;9
Smith CJ, Ryom L, Weber R, Morlat P, Pradier C, Reiss P
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration.
Lancet 2014;384
Anthony S, Pradier C, Chevrier R, Festraëts J, Tifratene K, Robert P
The French National Alzheimer database: a fast growing database for researchers and clinicians.
Dement Geriatr Cogn Disord 2014;38
Mocroft A, Ryom L, Begovac J, Monforte AD, Vassilenko A, Gatell J
Deteriorating renal function and clinical outcomes in HIV-positive persons.
AIDS 2014;28
Mocroft A, Reiss P, Rakhmanova A, Banhegyi D, Phillips AN, De Wit S
A survey of ATRIPLA use in clinical practice as first-line therapy in HIV-positive persons in Europe.
Infection 2014;42
Petoumenos K, Reiss P, Ryom L, Rickenbach M, Sabin CA, El-Sadr W
Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations.
HIV Med. 2014;15
Kamara DA, Ryom L, Ross M, Kirk O, Reiss P, Morlat P
Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: the D:A:D study.
BMC Nephrol 2014;15
Moore M, Stuart B, Coenen S, Butler CC, Goossens H, Verheij TJ
Amoxicillin for acute lower respiratory tract infection in primary care: subgroup analysis of potential high-risk groups.
Br J Gen Pract 2014;64
Mary-Krause M, Grabar S, Lièvre L, Abgrall S, Billaud E, Boué F
Cohort Profile: French hospital database on HIV (FHDH-ANRS CO4).
Int J Epidemiol 2014;43
Zoufaly A, Cozzi-Lepri A, Reekie J, Kirk O, Lundgren J, Reiss P
Immuno-virological discordance and the risk of non-AIDS and AIDS events in a large observational cohort of HIV-patients in Europe.
PLoS ONE 2014;9
Shepherd L, Souberbielle JC, Bastard JP, Fellahi S, Capeau J, Reekie J
Prognostic value of vitamin D level for all-cause mortality, and association with inflammatory markers, in HIV-infected persons.
J. Infect. Dis. 2014;210
Vassallo M, Durant J, Biscay V, Lebrun-Frenay C, Dunais B, Laffon M
Can high central nervous system penetrating antiretroviral regimens protect against the onset of HIV-associated neurocognitive disorders?
AIDS 2014;28
Grint D, Peters L, Rockstroh JK, de Wit S, Mitsura VM, Knysz B
Increased incidence of antiretroviral drug discontinuation among patients with viremic hepatitis C virus coinfection and high hyaluronic acid, a marker of liver fibrosis.
AIDS 2014;28
Blanc V, Leflon-Guibout V, Blanco J, Haenni M, Madec JY, Rafignon G
Prevalence of day-care centre children (France) with faecal CTX-M-producing Escherichia coli comprising O25b:H4 and O16:H5 ST131 strains.
J. Antimicrob. Chemother. 2014;69
Denis B, Sauleau EA, Gendre I, Exbrayat C, Piette C, Dancourt V
The mean number of adenomas per procedure should become the gold standard to measure the neoplasia yield of colonoscopy: a population-based cohort study.
Dig Liver Dis 2014;46
Tifratene K, Sakarovitch C, Rouis A, Pradier C, Robert P
Mild cognitive impairment and anti-Alzheimer disease medications: A cross sectional study of the French National Alzheimer Databank (BNA).
J. Alzheimers Dis. 2014;38
Delotte J, Barjoan EM, Berrébi A, Laffont C, Benos P, Pradier C
Obstetric management does not influence vertical transmission of HCV infection: results of the ALHICE group study.
J. Matern. Fetal. Neonatal. Med. 2014;27
Rosenthal E, Piroth L, Cua E, Joulié A, Ravaux I, Chauveau M
Preexposure prophylaxis (PrEP) of HIV infection in France: a nationwide cross-sectional study (PREVIC study).
AIDS Care 2014;26
Bruno P, Dunais B, Blanc V, Sakarovitch C, Touboul P, Anastay M, Nicolas-Chanoine MH, Pradier C
Portage digestif d’entérobactéries résistantes aux céphalosporines de 3e génération et productrices de bêta-lactamase à spectre étendu (BLSE) chez les enfants fréquentant les crèches collectives des Alpes-Maritimes en 2012
Bull Epidémiol Hebd. 2014;(24-25):416-21
Worm SW, Bower M, Reiss P, Bonnet F, Law M, Fätkenheuer G
Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study.
BMC Infect. Dis. 2013;13
Montlahuc C, Guiguet M, Abgrall S, Daneluzzi V, de Salvador F, Launay O
Impact of late presentation on the risk of death among HIV-infected people in France (2003-2009).
J. Acquir. Immune Defic. Syndr. 2013;64
Moranne O, Bakris G, Fafin C, Favre G, Pradier C, Esnault VL
Determinants and changes associated with aldosterone breakthrough after angiotensin II receptor blockade in patients with type 2 diabetes with overt nephropathy.
Clin J Am Soc Nephrol 2013;8
Little P, Stuart B, Francis N, Douglas E, Tonkin-Crine S, Anthierens S
Effects of internet-based training on antibiotic prescribing rates for acute respiratory-tract infections: a multinational, cluster, randomised, factorial, controlled trial.
Lancet 2013;382
Hleyhel M, Belot A, Bouvier AM, Tattevin P, Pacanowski J, Genet P
Risk of AIDS-defining cancers among HIV-1-infected patients in France between 1992 and 2009: results from the FHDH-ANRS CO4 cohort.
Clin. Infect. Dis. 2013;57
Grint D, Peters L, Schwarze-Zander C, Beniowski M, Pradier C, Battegay M
Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA.
HIV Med. 2013;14
Vassallo M, Dunais B, Durant J, Carsenti-Dellamonica H, Harvey-Langton A, Cottalorda J
Relevance of lipopolysaccharide levels in HIV-associated neurocognitive impairment: the Neuradapt study.
J. Neurovirol. 2013;19
Sabin CA, Ryom L, De Wit S, Mocroft A, Phillips AN, Worm SW
Associations between immune depression and cardiovascular events in HIV infection.
AIDS 2013;27
Baillif S, Leduff F, Hartmann DJ, Kodjikian L
Staphylococcus epidermidis biofilm formation and structural organization on different types of intraocular lenses under in vitro flow conditions.
Ophthalmic Res. 2013;50
Peters L, Mocroft A, Soriano V, Rockstroh J, Rauch A, Karlsson A
Hyaluronic acid levels predict risk of hepatic encephalopathy and liver-related death in HIV/viral hepatitis coinfected patients.
PLoS ONE 2013;8
Mocroft A, Phillips AN, Gatell J, Horban A, Ledergerber B, Zilmer K
CD4 cell count and viral load-specific rates of AIDS, non-AIDS and deaths according to current antiretroviral use.
AIDS 2013;27
van Vugt SF, Broekhuizen BD, Lammens C, Zuithoff NP, de Jong PA, Coenen S
Use of serum C reactive protein and procalcitonin concentrations in addition to symptoms and signs to predict pneumonia in patients presenting to primary care with acute cough: diagnostic study.
BMJ 2013;346
Sabin CA, Ryom L, Kovari H, Kirk O, de Wit S, Law M
Association between ALT level and the rate of cardio/cerebrovascular events in HIV-positive individuals: the D: A: D study.
J. Acquir. Immune Defic. Syndr. 2013;63
Grint D, Peters L, Reekie J, Soriano V, Kirk O, Knysz B
Stability of hepatitis C virus (HCV) RNA levels among interferon-naïve HIV/HCV-coinfected individuals treated with combination antiretroviral therapy.
HIV Med. 2013;14
Ryom L, Mocroft A, Kirk O, Worm SW, Kamara DA, Reiss P
Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study.
J. Infect. Dis. 2013;207
Parron S, Gentile S, Enel P, Benhaïm L, Ferrandino J, Bentz L
Patient education: state of the art of the programs in the region of Provence-Alpes-Côte d'Azur in 2008 before the publication of official documents relative to the authorizations of the Regional Health Agency (ARS)
Rev Epidemiol Sante Publique 2013;61
Vandenbos F, Fontas É, Dunais B, Daideri G, Pop D, Perrotin C
Pulmonary rehabilitation after lung resection for tumor - a feasibility study
Rev Mal Respir 2013;30
Monforte Ad, Reiss P, Ryom L, El-Sadr W, Dabis F, De Wit S
Atazanavir is not associated with an increased risk of cardio- or cerebrovascular disease events.
AIDS 2013;27
Little P, Stuart B, Moore M, Coenen S, Butler CC, Godycki-Cwirko M
Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial.
Lancet Infect Dis 2013;13
Coupat C, Pradier C, Degand N, Hofliger P, Pulcini C
Selective reporting of antibiotic susceptibility data improves the appropriateness of intended antibiotic prescriptions in urinary tract infections: a case-vignette randomised study.
Eur. J. Clin. Microbiol. Infect. Dis. 2013;32
Charpentier C, Joly V, Larrouy L, Fagard C, Visseaux B, de Verdière NC
Role and evolution of viral tropism in patients with advanced HIV disease receiving intensified initial regimen in the ANRS 130 APOLLO trial.
J. Antimicrob. Chemother. 2013;68
Chalabaev A, Emile M, Corrion K, Stephan Y, Clément-Guillotin C, Pradier C
Development and validation of the aging stereotypes and exercise scale.
J Aging Phys Act 2013;21
Tonkin-Crine S, Yardley L, Coenen S, Fernandez-Vandellos P, Krawczyk J, Touboul P
Strategies to promote prudent antibiotic use: exploring the views of professionals who develop and implement guidelines and interventions.
Fam Pract 2013;30
Abravanel F, Raymond S, Pambrun E, Winnock M, Bonnard P, Sogni P
HIV-1 tropism and liver fibrosis in HIV-HCV co-infected patients.
PLoS ONE 2012;7
van Vugt S, Broekhuizen L, Zuithoff N, de Jong P, Butler C, Hood K
Incidental chest radiographic findings in adult patients with acute cough.
Ann Fam Med 2012;10
May MT, Hogg RS, Justice AC, Shepherd BE, Costagliola D, Ledergerber B
Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics.
Int J Epidemiol 2012;41
Petoumenos K, Worm SW, Fontas E, Weber R, De Wit S, Bruyand M
Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.
J Int AIDS Soc 2012;15
Mocroft A, Bannister WP, Kirk O, Kowalska JD, Reiss P, D'Arminio-Monforte A
The clinical benefits of antiretroviral therapy in severely immunocompromised HIV-1-infected patients with and without complete viral suppression.
Antivir. Ther. (Lond.) 2012;17
Reekie J, Kowalska JD, Karpov I, Rockstroh J, Karlsson A, Rakhmanova A
Regional differences in AIDS and non-AIDS related mortality in HIV-positive individuals across Europe and Argentina: the EuroSIDA study.
PLoS ONE 2012;7
Solas C, Pambrun E, Winnock M, Salmon D, Poizot-Martin I, Dominguez S
Ribavirin and abacavir drug interaction in HIV-HCV coinfected patients: fact or fiction?
AIDS 2012;26
Peters L, Grint D, Lundgren JD, Rockstroh JK, Soriano V, Reiss P
Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients.
AIDS 2012;26
Tifratene K, Duff FL, Pradier C, Quetel J, Lafay P, Schück S
Use of drug treatments for Alzheimer's disease in France: a study on a national level based on the National Alzheimer's Data Bank (Banque Nationale Alzheimer).
Pharmacoepidemiol Drug Saf 2012;21
Vassallo M, Dunais B, Naqvi A, Garaffo R, Durant J
Raltegravir-induced nephrolithiasis: a case report.
AIDS 2012;26
Cain LE, Phillips A, Lodi S, Sabin C, Bansi L, Justice A
The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study.
AIDS 2012;26
del Amo J, Moreno S, Bucher HC, Furrer H, Logan R, Sterne J
Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries.
Clin. Infect. Dis. 2012;54
Salmon-Ceron D, Cohen J, Winnock M, Roux P, Sadr FB, Rosenthal E
Engaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France).
BMC Health Serv Res 2012;12
Le Duff F, Develay AE, Quetel J, Lafay P, Schück S, Pradier C
The 2008-2012 French Alzheimer plan: description of the national Alzheimer information system.
J. Alzheimers Dis. 2012;29
Gonfrier S, Andrieu S, Renaud D, Vellas B, Robert PH
Course of neuropsychiatric symptoms during a 4-year follow up in the REAL-FR cohort.
J Nutr Health Aging 2012;16
Baillif S, Roure-Sobas C, Le-Duff F, Kodjikian L
Aqueous humor contamination during phacoemulsification in a university teaching hospital.
J Fr Ophtalmol 2012;35
Bourcier V, Winnock M, Ait Ahmed M, Sogni P, Pambrun E, Poizot-Martin I
Primary liver cancer is more aggressive in HIV-HCV coinfection than in HCV infection. A prospective study (ANRS CO13 Hepavih and CO12 Cirvir).
Clin Res Hepatol Gastroenterol 2012;36
David R, Mulin E, Friedman L, Le Duff F, Cygankiewicz E, Deschaux O
Decreased daytime motor activity associated with apathy in Alzheimer disease: an actigraphic study.
Am J Geriatr Psychiatry 2012;20
Zeanandin G, Molato O, Le Duff F, Guérin O, Hébuterne X, Schneider SM
Impact of restrictive diets on the risk of undernutrition in a free-living elderly population.
Clin Nutr 2012;31
Cuzin L, Delpierre C, Yazdanpanah Y, Lert F
How long do physicians wait to start antiretroviral treatment in newly diagnosed HIV-infected patients?
HIV Clin Trials 2011;12
Touboul P, Valbousquet J, Pourrat-Vanoni I, Alquier MF, Benchimol D, Pradier C
Adapting the environment to encourage the elderly to walk: a qualitative study
Sante Publique 2011;23
Grenier C, Gambarelli F, Brami G, Kazarian H, Bottero J, Antoine D
Innovating for an EHPAD of the future: the suggestions of professionals in the Alpes-Maritimes (France)
Sante Publique 2011;23
Reekie J, Gatell JM, Yust I, Bakowska E, Rakhmanova A, Losso M
Fatal and nonfatal AIDS and non-AIDS events in HIV-1-positive individuals with high CD4 cell counts according to viral load strata.
AIDS 2011;25
Bailly L, Bongain A, Mariné Barjoan E, Sattonnet C, Saos J, Durant ML
Rate of cervical intraepithelial neoplasia before HPV vaccination, Alpes-Maritimes 2006
Gynecol Obstet Fertil 2011;39
Guittet L, Bailly L, Bouvier V, Launoy G
Indirect comparison of two quantitative immunochemical faecal occult blood tests in a population with average colorectal cancer risk.
J Med Screen 2011;18
Bailly L, Giusiano B, Barjoan EM, Michiels JF, Ambrosetti D, Lacombe S
Investigating the completeness of a histopathological cancer registry: estimation by capture-recapture analysis in a French geographical unit Alpes-Maritimes, 2008.
Cancer Epidemiol 2011;35
Paredes R, Puertas MC, Bannister W, Kisic M, Cozzi-Lepri A, Pou C
A376S in the connection subdomain of HIV-1 reverse transcriptase confers increased risk of virological failure to nevirapine therapy.
J. Infect. Dis. 2011;204
The impact of fasting on the interpretation of triglyceride levels for predicting myocardial infarction risk in HIV-positive individuals: the D:A:D study.
J. Infect. Dis. 2011;204
David R, Friedman L, Mulin E, Noda A, Le Duff F, Kennedy Q
Lack of Association Between COMT Polymorphisms and Apathy in Alzheimer's Disease.
J. Alzheimers Dis. 2011;27
Dunais B, van Dijken C, Bruno P, Touboul P, Carsenti-Dellamonica H, Pradier C
Antibiotic prescriptions in French day-care centres: 1999-2008.
Arch. Dis. Child. 2011;96
Bommenel T, Launay O, Meynard JL, Gilquin J, Katlama C, Lascaux AS
Comparative effectiveness of continuing a virologically effective first-line boosted protease inhibitor combination or of switching to a three-drug regimen containing either efavirenz, nevirapine or abacavir.
J. Antimicrob. Chemother. 2011;66
Tonkin-Crine S, Yardley L, Coenen S, Fernandez-Vandellos P, Krawczyk J, Touboul P
GPs' views in five European countries of interventions to promote prudent antibiotic use.
Br J Gen Pract 2011;61
Dunais B, Bruno-Bazureault P, Carsenti-Dellamonica H, Touboul P, Pradier C
A decade-long surveillance of nasopharyngeal colonisation with Streptococcus pneumoniae among children attending day-care centres in south-eastern France: 1999-2008.
Eur. J. Clin. Microbiol. Infect. Dis. 2011;30
Kruk A, Bannister W, Podlekareva DN, Chentsova NP, Rakhmanova AG, Horban A
Tuberculosis among HIV-positive patients across Europe: changes over time and risk factors.
AIDS 2011;25
Kowalska JD, Friis-Møller N, Kirk O, Bannister W, Mocroft A, Sabin C
The Coding Causes of Death in HIV (CoDe) Project: initial results and evaluation of methodology.
Epidemiology 2011;22
Viard JP, Souberbielle JC, Kirk O, Reekie J, Knysz B, Losso M
Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study.
AIDS 2011;25
Makinson A, Tenon JC, Eymard-Duvernay S, Pujol JL, Allavena C, Cuzin L
Human immunodeficiency virus infection and non-small cell lung cancer: survival and toxicity of antineoplastic chemotherapy in a cohort study.
J Thorac Oncol 2011;6
Cain LE, Logan R, Robins JM, Sterne JA, Sabin C, Bansi L
When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study.
Ann. Intern. Med. 2011;154
Kowalska JD, Mocroft A, Ledergerber B, Florence E, Ristola M, Begovac J
A standardized algorithm for determining the underlying cause of death in HIV infection as AIDS or non-AIDS related: results from the EuroSIDA study.
HIV Clin Trials 2011;12
Roux CH, Breuil V, Valerio L, Amoretti N, Brocq O, Albert C
Etanercept compared to intraarticular corticosteroid injection in rheumatoid arthritis: double-blind, randomized pilot study.
J. Rheumatol. 2011;38
Bannister WP, Cozzi-Lepri A, Kjær J, Clotet B, Lazzarin A, Viard JP
Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapy.
J. Antimicrob. Chemother. 2011;66
Mulin E, Zeitzer JM, Friedman L, Le Duff F, Yesavage J, Robert PH
Relationship between apathy and sleep disturbance in mild and moderate Alzheimer's disease: an actigraphic study.
J. Alzheimers Dis. 2011;25
Petoumenos K, Worm S, Reiss P, de Wit S, d'Arminio Monforte A, Sabin C
Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study(*).
HIV Med. 2011;12
Lanoy E, Guiguet M, Bentata M, Rouveix E, Dhiver C, Poizot-Martin I
Survival after neuroAIDS: association with antiretroviral CNS Penetration-Effectiveness score.
Neurology 2011;76
Taupiac M, Fafin C, Vivien M, Esnault V, Pradier C, Moranne O
Focusing on the steps to follow to initiate a clinical research project
Nephrol. Ther. 2011;7
Hiéronimus S, Lussiez V, Le Duff F, Ferrari P, Bständig B, Fénichel P
Klinefelter's syndrome and bone mineral density: is osteoporosis a constant feature?
Ann. Endocrinol. (Paris) 2011;72
Reekie J, Reiss P, Ledergerber B, Sedlacek D, Parczewski M, Gatell J
A comparison of the long-term durability of nevirapine, efavirenz and lopinavir in routine clinical practice in Europe: a EuroSIDA study.
HIV Med. 2011;12
Weber R, Sabin C, Reiss P, de Wit S, Worm SW, Law M
HBV or HCV coinfections and risk of myocardial infarction in HIV-infected individuals: the D:A:D Cohort Study.
Antivir. Ther. (Lond.) 2010;15
Loko MA, Salmon D, Carrieri P, Winnock M, Mora M, Merchadou L
The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006-2010.
BMC Infect. Dis. 2010;10
Lecky DM, McNulty CA, Touboul P, Herotova TK, Benes J, Dellamonica P
Evaluation of e-Bug, an educational pack, teaching about prudent antibiotic use and hygiene, in the Czech Republic, France and England.
J. Antimicrob. Chemother. 2010;65
Bentz L, Enel P, Dunais B, Durant J, Poizot-Martin I, Tourette-Turgis C
Evaluating counseling outcome on adherence to prophylaxis and follow-up after sexual HIV-risk exposure: a randomized controlled trial.
AIDS Care 2010;22
Trullas JC, Mocroft A, Cofan F, Tourret J, Moreno A, Bagnis CI
Dialysis and renal transplantation in HIV-infected patients: a European survey.
J. Acquir. Immune Defic. Syndr. 2010;55
Piroth L, Pol S, Lacombe K, Miailhes P, Rami A, Rey D
Management and treatment of chronic hepatitis B virus infection in HIV positive and negative patients: the EPIB 2008 study.
J. Hepatol. 2010;53
Fontas E, Kousignian I, Pradier C, Poizot-Martin I, Durier C, Weiss L
IL-2 therapy: potential impact of the CD4 cell count at initiation on clinical efficacy--results from the ANRS CO4 cohort.
J. Antimicrob. Chemother. 2010;65
Mocroft A, Reiss P, Gasiorowski J, Ledergerber B, Kowalska J, Chiesi A
Serious fatal and nonfatal non-AIDS-defining illnesses in Europe.
J. Acquir. Immune Defic. Syndr. 2010;55
Reekie J, Kosa C, Engsig F, Monforte Ad, Wiercinska-Drapalo A, Domingo P
Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies.
Cancer 2010;116
Lang S, Mary-Krause M, Cotte L, Gilquin J, Partisani M, Simon A
Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus-infected patients: a case-control study nested within the French Hospital Database on HIV ANRS cohort CO4.
Arch. Intern. Med. 2010;170
Balu-Maestro C, Bailly L, Granon C, Namer M
Screening digital mammography: one year result for the Alpes-Maritimes region
J Radiol 2010;91
Lodwick RK, Sabin CA, Porter K, Ledergerber B, van Sighem A, Cozzi-Lepri A
Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study.
Lancet 2010;376
Friis-Møller N, Thiébaut R, Reiss P, Weber R, Monforte AD, De Wit S
Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study.
Eur J Cardiovasc Prev Rehabil 2010;17
Mocroft A, Kirk O, Reiss P, De Wit S, Sedlacek D, Beniowski M
Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients.
AIDS 2010;24
Hyvernat H, Dunais B, Burel-Vandenbos F, Guidicelli S, Bernardin G, Gari-Toussaint M
Fatal peritonitis caused by Rhizopus microsporus.
Med. Mycol. 2010;48
Smith C, Sabin CA, Lundgren JD, Thiebaut R, Weber R, Law M
Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study.
AIDS 2010;24
Reekie J, Mocroft A, Ledergerber B, Beniowski M, Clotet B, van Lunzen J
History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change.
HIV Med. 2010;11
Abgrall S, Del Giudice P, Melica G, Costagliola D
HIV-associated tuberculosis and immigration in a high-income country: incidence trends and risk factors in recent years.
AIDS 2010;24
Soriano V, Mocroft A, Peters L, Rockstroh J, Antunes F, Kirkby N
Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe.
J. Antimicrob. Chemother. 2010;65
Michel L, Villes V, Dabis F, Spire B, Winnock M, Loko MA
Role of treatment for depressive symptoms in relieving the impact of fatigue in HIV-HCV co-infected patients: ANRS Co13 Hepavih, France, 2006-2008.
J. Viral Hepat. 2010;17
Fontaine D, Lazorthes Y, Mertens P, Blond S, Géraud G, Fabre N
Safety and efficacy of deep brain stimulation in refractory cluster headache: a randomized placebo-controlled double-blind trial followed by a 1-year open extension.
J Headache Pain 2010;11
Worm SW, Friis-Møller N, Bruyand M, D'Arminio Monforte A, Rickenbach M, Reiss P
High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome.
AIDS 2010;24
Kousignian I, Launay O, Mayaud C, Rabaud C, Costagliola D, Abgrall S
Does enfuvirtide increase the risk of bacterial pneumonia in patients receiving combination antiretroviral therapy?
J. Antimicrob. Chemother. 2010;65
Ray M, Logan R, Sterne JA, Hernández-Díaz S, Robins JM, Sabin C
The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals.
AIDS 2010;24
Tavolacci MP, Marini H, Bailly L, Ladner J
Prevalence and socio-health characteristic of hard-core smokers in Haute-Normandie
Sante Publique 2009;21
Mouala C, Guiguet M, Houzé S, Damond F, Pialoux G, Viget N
Impact of HIV infection on severity of imported malaria is restricted to patients with CD4 cell counts < 350 cells/microl.
AIDS 2009;23
Cozzi-Lepri A, Phillips AN, Martinez-Picado J, Monforte Ad, Katlama C, Eg Hansen AB
Rate of accumulation of thymidine analogue mutations in patients continuing to receive virologically failing regimens containing zidovudine or stavudine: implications for antiretroviral therapy programs in resource-limited settings.
J. Infect. Dis. 2009;200
Kesselring AM, Wit FW, Sabin CA, Lundgren JD, Gill MJ, Gatell JM
Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy.
AIDS 2009;23
Bailly L, Mariné-Barjoan E, Ambrosetti D, Roussel JF, Caissotti C, Ettore F
Data quality of cancer registration by Adicap codes, used by French pathologists from Paca, 2005-2006
Ann Pathol 2009;29
Peters L, Mocroft A, Soriano V, Rockstroh JK, Losso M, Valerio L
Hepatitis C virus coinfection does not influence the CD4 cell recovery in HIV-1-infected patients with maximum virologic suppression.
J. Acquir. Immune Defic. Syndr. 2009;50
Pitrou I, Lecourt AC, Bailly L, Brousse B, Dauchet L, Ladner J
Waiting time and assessment of patient satisfaction in a large reference emergency department: a prospective cohort study, France.
Eur J Emerg Med 2009;16
Mocroft A, Sterne JA, Egger M, May M, Grabar S, Furrer H
Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal.
Clin. Infect. Dis. 2009;48
Rosenthal E, Salmon-Céron D, Lewden C, Bouteloup V, Pialoux G, Bonnet F
Liver-related deaths in HIV-infected patients between 1995 and 2005 in the French GERMIVIC Joint Study Group Network (Mortavic 2005 study in collaboration with the Mortalité 2005 survey, ANRS EN19).
HIV Med. 2009;10
Lanoy E, Lewden C, Lièvre L, Tattevin P, Boileau J, Aouba A
How does loss to follow-up influence cohort findings on HIV infection? A joint analysis of the French hospital database on HIV, Mortalité 2000 survey and death certificates.
HIV Med. 2009;10
Fontas E, Kousignian I, Pradier C, Duvivier C, Poizot-Martin I, Durier C
Interleukine-2 therapy does not increase the risk of Hodgkin or non-Hodgkin lymphoma in HIV-infected patients: results from FHDH ANRS CO4.
J. Acquir. Immune Defic. Syndr. 2009;50
Serraino D, Piselli P
Cancer cohort consortium approach: cancer epidemiology in immunosuppressed groups.
Methods Mol. Biol. 2009;471
Worm SW, Sabin CA, Reiss P, El-Sadr W, Monforte Ad, Pradier C
Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) study.
Diabetes Care 2009;32
Tessonnier L, Gonfrier S, Carrier P, Valerio L, Mouroux J, Benisvy D
Unexpected focal bowel 18-FDG uptake sites: should they be systematically investigated?
Bull Cancer 2008;95
Mugavero MJ, May M, Harris R, Saag MS, Costagliola D, Egger M
Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?
AIDS 2008;22
Reekie J, Mocroft A, Sambatakou H, Machala L, Chiesi A, van Lunzen J
Does less frequent routine monitoring of patients on a stable, fully suppressed cART regimen lead to an increased risk of treatment failure?
AIDS 2008;22
Dunais B, Bruno P, Carsenti-Dellamonica H, Touboul P, Dellamonica P, Pradier C
Trends in nasopharyngeal carriage of Streptococcus pneumoniae among children attending daycare centers in southeastern France from 1999 to 2006.
Pediatr. Infect. Dis. J. 2008;27
Podlekareva D, Bannister W, Mocroft A, Abrosimova L, Karpov I, Lundgren JD
The EuroSIDA study: Regional differences in the HIV-1 epidemic and treatment response to antiretroviral therapy among HIV-infected patients across Europe--a review of published results.
Cent. Eur. J. Public Health 2008;16
Cozzi-Lepri A, Phillips AN, Clotet B, Mocroft A, Ruiz L, Kirk O
Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study.
AIDS 2008;22
Monforte Ad, Abrams D, Pradier C, Weber R, Reiss P, Bonnet F
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies.
AIDS 2008;22
Roux P, Carrieri MP, Villes V, Dellamonica P, Poizot-Martin I, Ravaux I
The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study.
Addiction 2008;103
Soriano V, Mocroft A, Rockstroh J, Ledergerber B, Knysz B, Chaplinskas S
Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe.
J. Infect. Dis. 2008;198
Blanc V, Bruno-Bazureault P, Malicki A, Berthier F, Dunais B, Touboul P
Antibiotics only when necessary' campaign in the Alpes-Maritimes district: no negative impact on invasive infections in children in the community 1998-2003
Presse Med 2008;37
Tavolacci MP, Ladner J, Bailly L, Merle V, Pitrou I, Czernichow P
Prevention of nosocomial infection and standard precautions: knowledge and source of information among healthcare students.
Infect Control Hosp Epidemiol 2008;29
Podlekareva D, Mocroft A, Kirk O, Reiss P, Aldins P, Katlama C
Fungal infection as a risk factor for HIV disease progression among patients with a CD4 count above 200/microl in the era of cART.
Scand. J. Infect. Dis. 2008;40
Bannister WP, Cozzi-Lepri A, Clotet B, Mocroft A, Kjaer J, Reiss P
Transmitted drug resistant HIV-1 and association with virologic and CD4 cell count response to combination antiretroviral therapy in the EuroSIDA Study.
J. Acquir. Immune Defic. Syndr. 2008;48
Piketty C, Selinger-Leneman H, Grabar S, Duvivier C, Bonmarchand M, Abramowitz L
Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy.
AIDS 2008;22
Brucker-Davis F, Wagner-Mahler K, Delattre I, Ducot B, Ferrari P, Bongain A
Cryptorchidism at birth in Nice area (France) is associated with higher prenatal exposure to PCBs and DDE, as assessed by colostrum concentrations.
Hum. Reprod. 2008;23
Rouzier C, Haudebourg J, Carpentier X, Valério L, Amiel J, Michiels JF
Detection of the TMPRSS2-ETS fusion gene in prostate carcinomas: retrospective analysis of 55 formalin-fixed and paraffin-embedded samples with clinical data.
Cancer Genet. Cytogenet. 2008;183
Sabin CA, d'Arminio Monforte A, Friis-Moller N, Weber R, El-Sadr WM, Reiss P
Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction.
Clin. Infect. Dis. 2008;46
Avettand-Fènoël V, Boufassa F, Galimand J, Meyer L, Rouzioux C
HIV-1 DNA for the measurement of the HIV reservoir is predictive of disease progression in seroconverters whatever the mode of result expression is.
J. Clin. Virol. 2008;42
Mocroft A, Kirk O, Aldins P, Chies A, Blaxhult A, Chentsova N
Loss to follow-up in an international, multicentre observational study.
HIV Med. 2008;9
Sabin CA, Worm SW, Weber R, Reiss P, El-Sadr W, Dabis F
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration.
Lancet 2008;371
Grabar S, Lanoy E, Allavena C, Mary-Krause M, Bentata M, Fischer P
Causes of the first AIDS-defining illness and subsequent survival before and after the advent of combined antiretroviral therapy.
HIV Med. 2008;9
Valerio L, Yazdanpanah Y, Poizot-Martin I, Rosenthal E, Marimoutou C, Gastaut JA
Baseline CD4 cell count and outcome of pegylated interferon plus ribavirin therapy in HIV/hepatitis C virus-coinfected patients.
J. Acquir. Immune Defic. Syndr. 2008;47
Paillard F, Catheline D, Duff FL, Bouriel M, Deugnier Y, Pouchard M
Plasma palmitoleic acid, a product of stearoyl-coA desaturase activity, is an independent marker of triglyceridemia and abdominal adiposity.
Nutr Metab Cardiovasc Dis 2008;18
Abakar-Mahamat A, Filippi J, Pradier C, Dozol A, Hébuterne X
Incidence of inflammatory bowel disease in Corsica from 2002 to 2003.
Gastroenterol. Clin. Biol. 2007;31
Serraino D, Piselli P, Busnach G, Burra P, Citterio F, Arbustini E
Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe.
Eur. J. Cancer 2007;43
Mariné-Barjoan E, Berrébi A, Giordanengo V, Favre SF, Haas H, Moreigne M
HCV/HIV co-infection, HCV viral load and mode of delivery: risk factors for mother-to-child transmission of hepatitis C virus?
AIDS 2007;21
Potard V, Rey D, Mokhtari S, Frixon-Marin V, Pradier C, Rozenbaum W
First-line highly active antiretroviral regimens in 2001-2002 in the French Hospital Database on HIV: combination prescribed and biological outcomes.
Antivir. Ther. (Lond.) 2007;12
Lucidarme D, Decoster A, Fremaux D, Harbonnier J, Jacob C, Vosgien V
Routine practice HCV infection screening with saliva samples: multicentric study in an intravenous drug user population.
Gastroenterol. Clin. Biol. 2007;31
Pitrou I, Dauchet L, Bailly L, Koubi SE, Tavolacci MP, Ladner J
Mobile phone follow-up of subjects included in a prospective cohort study: unexpected difficulties.
Eur. J. Epidemiol. 2007;22
Boileau P, Baqué F, Valerio L, Ahrens P, Chuinard C, Trojani C
Isolated arthroscopic biceps tenotomy or tenodesis improves symptoms in patients with massive irreparable rotator cuff tears.
J Bone Joint Surg Am 2007;89
Ciais JF, Pradier C, Ciais C, Berthier F, Vallageas M, Raucoules-Aime M
Impact of a hospice home visit team on unwanted hospitalization of terminally-ill patients at home in acute medical emergencies
Presse Med 2007;36
Rosenthal E, Pialoux G, Bernard N, Pradier C, Rey D, Bentata M
Liver-related mortality in human-immunodeficiency-virus-infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study).
J. Viral Hepat. 2007;14
Busnach G, Piselli P, Arbustini E, Baccarani U, Burra P, Carrieri MP
Immunosuppression and cancer: A comparison of risks in recipients of organ transplants and in HIV-positive individuals.
Transplant. Proc. 2006;38
Weber R, Sabin CA, Friis-Møller N, Reiss P, El-Sadr WM, Kirk O
Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study.
Arch. Intern. Med. 2006;166
Bruno-Bazureault P, Touboul P, Hofliger P, Mariné-Barjoan E, Pradier C, Patuano C
Peer visits to community-based general practitioners and pediatricians as part of the 'Antibiotics only when necessary' campaign in the Alpes-Maritimes district. Methodology, feasibility, and interest
Presse Med 2006;35
Bentz L, Benmansour EH, Pradier C
An epidemic of unidentified illness experienced by a hospital's staff: a qualitative study
Sante Publique 2006;18
Law MG, Friis-Møller N, El-Sadr WM, Weber R, Reiss P, D'Arminio Monforte A
The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study.
HIV Med. 2006;7
Lasbleiz J, Askri A, Le Duff F, Decaux O, Marin F, Duvauferrier R
Diffusion weighted MRI of spine tumors
J Radiol 2006;87
Lampe FC, Gatell JM, Staszewski S, Johnson MA, Pradier C, Gill MJ
Changes over time in risk of initial virological failure of combination antiretroviral therapy: a multicohort analysis, 1996 to 2002.
Arch. Intern. Med. 2006;166
Malafronte B, Perbost I, Pradier C, Bentz L, Dunais B, Dellamonica P
What do HIV-infected patients become after an opportunistic infection?
AIDS 2006;20
Pulcini C, Pradier C, Samat-Long C, Hyvernat H, Bernardin G, Ichai C
Factors associated with adherence to infectious diseases advice in two intensive care units.
J. Antimicrob. Chemother. 2006;57
Burgun A, Darmoni S, Duff FL, Wéber J
Problem-based learning in medical informatics for undergraduate medical students: an experiment in two medical schools.
Int J Med Inform 2006;75
Serraino D, Angeletti C, Carrieri MP, Longo B, Piche M, Piselli P
Kaposi's sarcoma in transplant and HIV-infected patients: an epidemiologic study in Italy and France.
Transplantation 2005;80
Bafghi A, Valerio L, Benizri EI, Trastour C, Benizri EJ, Bongain A
Comparison between monofilament and multifilament polypropylene tapes in urinary incontinence.
Eur. J. Obstet. Gynecol. Reprod. Biol. 2005;122
Carsenti-Dellamonica H, Galimand M, Vandenbos F, Pradier C, Roger PM, Dunais B
In vitro selection of mutants of Streptococcus pneumoniae resistant to macrolides and linezolid: relationship with susceptibility to penicillin G or macrolides.
J. Antimicrob. Chemother. 2005;56
Costagliola D, Potard V, Duvivier C, Pradier C, Dupont C, Salmon D
Impact of newly available drugs on clinical progression in patients with virological failure after exposure to three classes of antiretrovirals.
Antivir. Ther. (Lond.) 2005;10
Perbost I, Malafronte B, Pradier C, Santo LD, Dunais B, Counillon E
In the era of highly active antiretroviral therapy, why are HIV-infected patients still admitted to hospital for an inaugural opportunistic infection?
HIV Med. 2005;6
Valerio L, Fontas E, Pradier C, Lavrut T, Garraffo R, Dunais B
Lopinavir/ritonavir combination and total/HDL cholesterol ratio.
J. Infect. 2005;50
Bafghi A, Valerio L, Trastour C, Benizri E, Bongain A
Evaluation of the TVT technique according to age
J Gynecol Obstet Biol Reprod (Paris) 2005;34
Pouliquen B, Le Duff F, Delamarre D, Cuggia M, Mougin F, Le Beux P
Managing educational resource in medicine: system design and integration.
Int J Med Inform 2005;74
Zweigenbaum P, Baud R, Burgun A, Namer F, Jarrousse E, Grabar N
UMLF: a unified medical lexicon for French.
Int J Med Inform 2005;74
Le Duff F, Daniel S, Kamendjé B, Le Beux P, Duvauferrier R
Monitoring incident report in the healthcare process to improve quality in hospitals.
Int J Med Inform 2005;74
Dunais B, Carsenti-Dellamonica H, Bruno P, Touboul P, Hofliger P, Maurin S
Type of child care and nasopharyngeal S. pneumoniae and H. influenzae carriage in children in the Alpes-Maritimes
Presse Med 2004;33
Mariné-Barjoan E, Saint-Paul MC, Pradier C, Chaillou S, Anty R, Michiels JF
Impact of antiretroviral treatment on progression of hepatic fibrosis in HIV/hepatitis C virus co-infected patients.
AIDS 2004;18
d'Arminio A, Sabin CA, Phillips AN, Reiss P, Weber R, Kirk O
Cardio- and cerebrovascular events in HIV-infected persons.
AIDS 2004;18
Fontas E, van Leth F, Sabin CA, Friis-Møller N, Rickenbach M, d'Arminio Monforte A
Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?
J. Infect. Dis. 2004;189
Friis-Møller N, Sabin CA, Weber R, d'Arminio Monforte A, El-Sadr WM, Reiss P
Combination antiretroviral therapy and the risk of myocardial infarction.
N. Engl. J. Med. 2003;349
Prouvost-Keller B, Hofliger P, Pradier C, Mondain V, Caselles D, Dellamonica P
Assessment of the habits of physicians involved in the management of HIV-infected patients. A clinical audit on the biological follow-up
Presse Med 2003;32
Rosenthal E, Poirée M, Pradier C, Perronne C, Salmon-Ceron D, Geffray L
Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study).
AIDS 2003;17
Dunais B, Pradier C, Carsenti H, Sabah M, Mancini G, Fontas E
Influence of child care on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae.
Pediatr. Infect. Dis. J. 2003;22
Pradier C, Carrieri MP, Piche M, Rosenthal E, Dellamonica P, Serraino D
Hepatitis C virus infection and cancer risk among HIV-infected individuals.
Infection 2003;31
Friis-Møller N, Weber R, Reiss P, Thiébaut R, Kirk O, d'Arminio Monforte A
Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.
AIDS 2003;17
Dabernat H, Plisson-Sauné MA, Delmas C, Séguy M, Faucon G, Pélissier R
Haemophilus influenzae carriage in children attending French day care centers: a molecular epidemiological study.
J. Clin. Microbiol. 2003;41
Pradier C, Bentz L, Spire B, Tourette-Turgis C, Morin M, Souville M
Efficacy of an educational and counseling intervention on adherence to highly active antiretroviral therapy: French prospective controlled study.
HIV Clin Trials 2003;4
Law M, Friis-Møller N, Weber R, Reiss P, Thiebaut R, Kirk O
Modelling the 3-year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) study.
HIV Med. 2003;4
Carrieri MP, Pradier C, Piselli P, Piche M, Rosenthal E, Heudier P
Reduced incidence of Kaposi's sarcoma and of systemic non-hodgkin's lymphoma in HIV-infected individuals treated with highly active antiretroviral therapy.
Int. J. Cancer 2003;103
Amedeo J, Occelli G, Pradier C, Grimaud D
Impact of the development of anesthesia protocols on the incidence of peri-anesthetic anaphylactoid reactions
Allerg Immunol (Paris) 2002;34
del Giudice P, Mary-Krause M, Pradier C, Grabar S, Dellamonica P, Marty P
Impact of highly active antiretroviral therapy on the incidence of visceral leishmaniasis in a French cohort of patients infected with human immunodeficiency virus.
J. Infect. Dis. 2002;186
Bongain A, Berrebi A, Mariné-Barjoan E, Dunais B, Thene M, Pradier C
Changing trends in pregnancy outcome among HIV-infected women between 1985 and 1997 in two southern French university hospitals.
Eur. J. Obstet. Gynecol. Reprod. Biol. 2002;104
Kirk O, Reiss P, Uberti-Foppa C, Bickel M, Gerstoft J, Pradier C
Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapy.
Ann. Intern. Med. 2002;137
Ciais JF, Ciais C, Pradier C, Marchand P, Lenoble C, Raucoules-Aimé M
Emergencies in patients undergoing palliative care at home. A qualitative study of telephone calls to Center 15
Presse Med 2002;31
Monpoux F, Berlioz M, Pradier C, Haas H, Boutte P
HIV exposure accidents in children. Experience at the emergency admission services of the CHU of Nice
Arch Pediatr 2002;9
Mariné-Barjoan E, Fontas E, Pradier C, Ouzan D, Saint-Paul MC, Sattonnet C
Registry of liver biopsies from hepatitis C infected patients in the Alpes-Maritimes (France). Results from the first 2 years
Gastroenterol. Clin. Biol. 2002;26
Roger PM, Martin C, Taurel M, Fournier JP, Nicole I, Carles M
Motives for the prescription of antibiotics in the emergency department of the University Hospital Center in Nice. A prospective study
Presse Med 2002;31
Phillips AN, Pradier C, Lazzarin A, Clotet B, Goebel FD, Hermans P
Viral load outcome of non-nucleoside reverse transcriptase inhibitor regimens for 2203 mainly antiretroviral-experienced patients.
AIDS 2001;15
Rosenthal E, Tempesta S, Del Giudice P, Marty P, Desjeux P, Pradier C
Declining incidence of visceral leishmaniasis in HIV-infected individuals in the era of highly active antiretroviral therapy.
AIDS 2001;15
Kirk O, Mocroft A, Pradier C, Bruun JN, Hemmer R, Clotet B
Clinical outcome among HIV-infected patients starting saquinavir hard gel compared to ritonavir or indinavir.
AIDS 2001;15
Pradier C, Carrieri P, Bentz L, Spire B, Dellamonica P, Moreau J
Impact of short-term adherence on virological and immunological success of HAART: a case study among French HIV-infected IDUs.
Int J STD AIDS 2001;12
Ledergerber B, Mocroft A, Reiss P, Furrer H, Kirk O, Bickel M
Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. Eight European Study Groups.
N. Engl. J. Med. 2001;344
Reynaud-Maurupt C, Carrieri MP, Gastaud JA, Pradier C, Obadia Y, Moatti JP
Impact of drug maintenance treatment on injection practices among French HIV-infected IDUs. The MANIF 2000 Study Group.
AIDS Care 2000;12
Mocroft A, Katlama C, Johnson AM, Pradier C, Antunes F, Mulcahy F
AIDS across Europe, 1994-98: the EuroSIDA study.
Lancet 2000;356
Rosenthal E, Marty P, del Giudice P, Pradier C, Ceppi C, Gastaut JA
HIV and Leishmania coinfection: a review of 91 cases with focus on atypical locations of Leishmania.
Clin. Infect. Dis. 2000;31
Tran A, Benzaken S, Saint-Paul MC, Guzman-Granier E, Hastier P, Pradier C
Chondrex (YKL-40), a potential new serum fibrosis marker in patients with alcoholic liver disease.
Eur J Gastroenterol Hepatol 2000;12
Rotily M, Bentz L, Pradier C, Obadia Y, Cavailler P
Factors related to delayed diagnosis of HIV infection in southeastern France. EVALVIH group.
Int J STD AIDS 2000;11
Tran A, Hastier P, Barjoan EM, Demuth N, Pradier C, Saint-Paul MC
Non invasive prediction of severe fibrosis in patients with alcoholic liver disease.
Gastroenterol. Clin. Biol. 2000;24
Pradier C, Keita-Perse O, Bernard E, Gisbert C, Vezolles MJ, Armengaud A
Outbreak of typhoid fever on the French Riviera.
Eur. J. Clin. Microbiol. Infect. Dis. 2000;19
Tran A, Longo F, Ouzan D, Bianchi D, Pradier C, Saint-Paul MC
Effects of 1-year interferon-alpha 2a treatment in patients with chronic hepatitis C and persistently normal transaminase activity.
Scand. J. Gastroenterol. 2000;35
Serraino D, Boschini A, Carrieri P, Pradier C, Dorrucci M, Dal Maso L
Cancer risk among men with, or at risk of, HIV infection in southern Europe.
AIDS 2000;14
Grabar S, Pradier C, Le Corfec E, Lancar R, Allavena C, Bentata M
Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor.
AIDS 2000;14
Pradier C, Rotily M, Bentz L, Cavailler P, Obadia Y
Epidemiological surveillance of HIV-seropositive subjects identified in Provence-Alpes-Cote d'Azur in 1996-1997
Presse Med 1999;28
Pradier C, Pesce A, Carrieri P, Cottalorda J, Boyer P, Senesi C
Effect of indinavir and higher CD4+ T-cell count on viral load response after 6 months of highly active antiretroviral therapy.
Clin Ther 1999;21
Pradier C, Rotily M, Cavailler P, Haas H, Pesce A, Dellamonica P
Factors related to the prescription of antibiotics for young children with viral pharyngitis by general practitioners and paediatricians in southeastern France.
Eur. J. Clin. Microbiol. Infect. Dis. 1999;18
Carsenti-Etesse H, Doyon F, Desplaces N, Gagey O, Tancrède C, Pradier C
Epidemiology of bacterial infection during management of open leg fractures.
Eur. J. Clin. Microbiol. Infect. Dis. 1999;18
Pradier C, Dunais B, Carsenti-Etesse H, Cavailler P, Haas H, Boutin-Andreu L
Nasopharyngeal carriage of resistance pneumococci in day-care centers in the Alps-Maritimes region
Pathol. Biol. 1999;47
Serraino D, Carrieri P, Pradier C, Bidoli E, Dorrucci M, Ghetti E
Risk of invasive cervical cancer among women with, or at risk for, HIV infection.
Int. J. Cancer 1999;82
Mocroft A, Kirk O, Barton SE, Dietrich M, Proenca R, Colebunders R
Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study group.
AIDS 1999;13
Rosenthal E, Pradier C, Keita-Perse O, Altare J, Dellamonica P, Cassuto JP
Needlestick injuries among French medical students.
JAMA 1999;281
Keita-Perse O, Pradier C, Rosenthal E, Altare J, Cassuto JP, Dellamonica P
Hospital medical students: a population at risk for accidental exposure to blood
Presse Med 1998;27
Peyrade F, Taillan B, Pradier C, Heudier P, Zanaldi H, Rafaelli C
Lung cancer in patients infected with human immunodeficiency virus. Clinical course and therapeutic implications
Presse Med 1998;27
Pradier C, Messiah A, Carrieri P, Rey D, Obadia Y, Moatti JP
Trends in HIV prenatal screening from 1992 to 1994 in South Eastern France
Rev Epidemiol Sante Publique 1998;46
Rey D, Carrieri MP, Obadia Y, Pradier C, Moatti JP
Mandatory prenatal screening for the human immunodeficiency virus: the experience in south-eastern France of a national policy, 1992-1994.
Br J Obstet Gynaecol 1998;105
Pradier C, Dunais B, Largillier R, Carsenti-Etesse H, Bernard E, Scheimberg A
Nasopharyngeal carriage of Streptococcus pneumoniae in children's day-care centers: 10-month follow-up study in Nice, France.
Clin. Microbiol. Infect. 1997;3
Pradier C, Dunais B, Carsenti-Etesse H, Dellamonica P
Pneumococcal resistance patterns in Europe.
Eur. J. Clin. Microbiol. Infect. Dis. 1997;16
Pradier C, Pesce A, Taillan B, Roger PM, Bentz L, Dellamonica P
Reducing the incidence of Pneumocystis carinii pneumonia: a persisting challenge.
AIDS 1997;11
Bernardin G, Pradier C, Tiger F, Deloffre P, Mattei M
Blood pressure and arterial lactate level are early indicators of short-term survival in human septic shock.
Intensive Care Med 1996;22
Bentz L, Pradier C, Caratti M, Ryvlin S, Dellamonica P
Sale of devices for intravenous injection to drug abusers. A survey of pharmacies in Nice 1995
Presse Med 1996;25
Bernard E, Carles M, Pradier C, Ozouf N, Dellamonica P
Community-acquired and nosocomial septicemias in patients with human immunodeficiency virus infection
Presse Med 1996;25
Carsenti-Etesse H, Durant J, De Salvador F, Bensoussan M, Bensoussan F, Pradier C
In vitro development of resistance of Streptococcus pneumoniae to beta-lactam antibiotics.
Microb. Drug Resist. 1995;1
Pradier C, Demeulemeester R, Nadal JM, Bourdillon F, Delfraissy JF, Bez G
Absence of regular medical follow-up: main cause of pneumocystosis diagnosed in patients with HIV infection in France in 1992
Presse Med 1995;24
Carsenti-Etesse H, Durant J, De Salvador F, Bensoussan M, Bensoussan F, Pradier C
In-vitro development of resistance to beta-lactam antibiotics in Streptococcus pneumoniae.
J. Antimicrob. Chemother. 1995;36
Bernard E, Carles M, Pradier C, Boissy C, Roger PM, Hebuterne X
Persistent diarrhea in HIV infected patients: role of Enterocytozoon bieneusi
Presse Med 1995;24
 
Contact
Liens
Mentions légales
CHU de Nice